2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Breast
1
Conditions
Breast Neoplasms
13
Neoplasms
12
Colorectal Neoplasms
12
Pain
11
Pain, Postoperative
9
Prostatic Neoplasms
7
Lung Neoplasms
7
Agnosia
6
Colonic Neoplasms
5
Cancer Pain
5
Neuralgia
4
Keratosis, Actinic
4
Head and Neck Neoplasms
4
Liver Neoplasms
3
Leiomyoma
3
Chronic Pain
3
Thyroid Neoplasms
2
Stomatitis
2
Stomach Neoplasms
2
Recurrence
2
Pilonidal Sinus
2
Oropharyngeal Neoplasms
2
Neuroma
2
Neoplasm Metastasis
2
Myofibroma
2
Mucositis
2
Inflammatory Bowel Diseases
2
Ileus
2
Diverticulitis
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
Morphine
2
ziconotide
1
rimabotulinumtoxinB
1
Syringes
1
Psilocybin
1
Plastic Surgery Procedures
1
Oxaliplatin
1
Massage
1
Low-Level Light Therapy
1
Lidocaine
1
Leucovorin
1
Gels
1
Fluorouracil
1
Ethanol
1
Erythromycin
1
Botulinum Toxins, Type A
1
Bandages
1
Bacitracin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Wounds and Injuries
×
Lidocaine
×
Clear all
NCT05800834
2023-09-28
MorphineGEL
Instituto Nacional de Cancer, Brazil
Phase 2
Unknown
106 enrolled